Esiti con IABP femorale nell'insufficienza cardiaca e nel shock cardiogeno acuto correlato all'infarto miocardico.

BACKGROUND: Intra-aortic balloon pump (IABP) insertion has not been shown to improve mortality rates in acute myocardial infarction-related cardiogenic shock (AMI-CS) but is increasingly used in heart failure-related cardiogenic shock (HF-CS). OBJECTIVE: We sought to compare IABP-related outcomes in patients with HF-CS and AMI-CS. METHODS: The Cardiogenic Shock Working Group registry was queried for patients with CS receiving femoral IABPs as the first temporary mechanical circulatory support (tMCS) device. Patients were divided into those with AMI-CS or HF-CS and were excluded if they received the IABP in conjunction with venoarterial extracorporeal membrane oxygenation (VA-ECMO) or anoth